MedPath

Long-term of 10 Years Results of a Prospective Longitudinal Study

Conditions
Type 2 Diabetes Mellitus
Blood Pressure
Interventions
Procedure: Blood pressure measurement based on HBP or CBP
Registration Number
NCT01557972
Lead Sponsor
Nagaoka Red Cross Hospital
Brief Summary

Previous cross-sectional studies have demonstrated that blood pressure (BP) measurements at home (HBP) in the morning offer stronger predictive power for micro- and macrovascular complications in patients with type 1 and 2 diabetes than casual/clinic blood pressure measurements (CBP) (Kamoi K et al, 2002-2003). Further, a prospective, longitudinal study for 6 years in patients with type 2 diabetes also demonstrated that control of wakening-up HBP provides the stronger predictive power for the outcomes than that of CBP did (Kamoi et al, 2010).

However, it is not clear to show which of BP measurement provides the stronger predictive power for outcomes by comparing cumulative events over a longer time than 6 years. Therefore, the investigators examined which of HBP or CBP provides the stronger predictive power for outcomes in addition of renal anemia reported previously over 10 years in the patients with type 2 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • After a detailed baseline examination, 400 Japanese subjects with type 2 diabetes reported previously are followed up for all-cause mortality and morbidity.
Exclusion Criteria
  • Other than the above, patients judged inappropriate as the subjects of this study by the investigator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1. Morning HP and NTBlood pressure measurement based on HBP or CBPSubjects based on HBP were divided into MH and MN patients
2. Clinic HP and NTBlood pressure measurement based on HBP or CBPSubjects based on CBP were divided into CH and CN patients
Primary Outcome Measures
NameTimeMethod
DeathAverage time is 10 years

Number of participats not alive

Secondary Outcome Measures
NameTimeMethod
Macrovascular complicationsAverage time is 10 years
Microvascular complications including renal anemiaAverage time is 10 years

Trial Locations

Locations (1)

Nagaoka Red Cross Hospital

🇯🇵

Nagaoka, Niigata, Japan

© Copyright 2025. All Rights Reserved by MedPath